Form 4: InspireMD Director Discloses Trust's Beneficial Ownership of Common Stock and Warrants
Insider Ownership Disclosure
InspireMD, Inc. Director Michael Berman filed a Form 4 to disclose the beneficial ownership of common stock and Series I Warrants held by the Michael Berman Revocable Trust, clarifying no direct transaction was effected by the reporting person.
Summary
- InspireMD, Inc. Director Michael Berman filed a Form 4 to report beneficial ownership of securities held by the Michael Berman Revocable Trust.
- The filing indicates the acquisition of 61,248 shares of Common Stock at a price of $1.3827 per share, held indirectly by the Michael Berman Revocable Trust.
- The trust also acquired 61,248 Series I Warrants with an exercise price of $1.3827, which were exercisable as of May 15, 2023, and expired on July 23, 2025.
- Following the reported events, the Michael Berman Revocable Trust beneficially owns 244,994 shares of Common Stock indirectly, and 0 Series I Warrants.
- Michael Berman also directly holds 264,533 shares of Common Stock.
- The filing explicitly states that no transaction was effected by Michael Berman himself with respect to these securities, and they are included for informational purposes only.
Sentiment
Score: 5
Explanation: The filing is neutral as it is an informational disclosure of beneficial ownership by a trust associated with a director, explicitly stating no direct transaction was effected by the reporting person. It does not indicate new market activity or provide performance insights.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing is a standard regulatory disclosure of beneficial ownership by an insider's associated entity and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding the beneficial ownership of a director's associated trust, but does not indicate new investment or divestment by the director personally.
Key Dates
| Date | Description |
|---|---|
| 05/15/2023 | Date Series I Warrants became exercisable. |
| 06/29/2025 | Transaction date for the acquisition of common stock and Series I Warrants by the Michael Berman Revocable Trust (for informational purposes). |
| 07/23/2025 | Expiration date of Series I Warrants and signature date of the Form 4 filing. |
Keywords
InspireMD, NSPR, Michael Berman, Form 4, Beneficial Ownership, Common Stock, Warrants, Director, SEC Filing, Trust Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.